Enterocolic increase of cannabinoid receptor type 1 and type 2 and clinical improvement after probiotic administration in dogs with chronic signs of colonic dysmotility without mucosal inflammatory changes - Rossi - 2020

Di uno scrittore di uomini misteriosi

Descrizione

Enterocolic increase of cannabinoid receptor type 1 and type 2 and clinical  improvement after probiotic administration in dogs with chronic signs of  colonic dysmotility without mucosal inflammatory changes - Rossi - 2020
Cannabidiol - Help and hype in targeting mucosal diseases - ScienceDirect
Enterocolic increase of cannabinoid receptor type 1 and type 2 and clinical  improvement after probiotic administration in dogs with chronic signs of  colonic dysmotility without mucosal inflammatory changes - Rossi - 2020
Cannabinoid receptor type 1 and 2 expression in the skin of healthy dogs and dogs with atopic dermatitis in: American Journal of Veterinary Research Volume 73 Issue 7 ()
Enterocolic increase of cannabinoid receptor type 1 and type 2 and clinical  improvement after probiotic administration in dogs with chronic signs of  colonic dysmotility without mucosal inflammatory changes - Rossi - 2020
Molecules, Free Full-Text
Enterocolic increase of cannabinoid receptor type 1 and type 2 and clinical  improvement after probiotic administration in dogs with chronic signs of  colonic dysmotility without mucosal inflammatory changes - Rossi - 2020
Targeting the endocannabinoid system for the treatment of abdominal pain in irritable bowel syndrome
Enterocolic increase of cannabinoid receptor type 1 and type 2 and clinical  improvement after probiotic administration in dogs with chronic signs of  colonic dysmotility without mucosal inflammatory changes - Rossi - 2020
PDF) Rapid Resolution of Large Bowel Diarrhea after the Administration of a Combination of a High-Fiber Diet and a Probiotic Mixture in 30 Dogs
Enterocolic increase of cannabinoid receptor type 1 and type 2 and clinical  improvement after probiotic administration in dogs with chronic signs of  colonic dysmotility without mucosal inflammatory changes - Rossi - 2020
Jan SUCHODOLSKI, Professor, MedVet, DrMedVet, PhD, AGAF, Diplomate ACVM, Texas A&M University, Texas, TAMU, Department of Small Animal Clinical Sciences
Enterocolic increase of cannabinoid receptor type 1 and type 2 and clinical  improvement after probiotic administration in dogs with chronic signs of  colonic dysmotility without mucosal inflammatory changes - Rossi - 2020
Frontiers Probiotics, prebiotics, and synbiotics in chronic constipation: Outstanding aspects to be considered for the current evidence
Enterocolic increase of cannabinoid receptor type 1 and type 2 and clinical  improvement after probiotic administration in dogs with chronic signs of  colonic dysmotility without mucosal inflammatory changes - Rossi - 2020
Molecules, Free Full-Text
Enterocolic increase of cannabinoid receptor type 1 and type 2 and clinical  improvement after probiotic administration in dogs with chronic signs of  colonic dysmotility without mucosal inflammatory changes - Rossi - 2020
Role of CB1 receptors in the acute regulation of small intestinal permeability: effects of high-fat diet
da per adulto (il prezzo varia in base alle dimensioni del gruppo)